EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Perspective on in vivo SPME for human applications: Starting from monitoring doxorubicin during lung chemo-perfusion

Wei Zhou, Runshan Will Jiang, Barbara Bojko, Janusz Pawliszyn

Journal of Pharmaceutical Analysis · 2024-07 · 14 (7) · 100918

DOI: 10.1016/j.jpha.2023.12.008 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Pharmaceutical Analysis, 2024-07. Verfasst von Wei Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Waterloo, Waterloo, ON N2L 3G1, Canada. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, National Institute of Mental Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Chemistry, University of Waterloo, Waterloo, ON N2L 3G1, Canada.
  • Department of Pharmacodynamics and Molecular Pharmacology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 85-089, Bydgoszcz, Poland.

Förderung

  • Natural Sciences and Engineering Research Council of Canada
  • National Institute of Mental Health

Zitieren

APA

Zhou, W., Jiang, R. W., Bojko, B., & Pawliszyn, J. (2024). Perspective on in vivo SPME for human applications: Starting from monitoring doxorubicin during lung chemo-perfusion. Journal of Pharmaceutical Analysis, 14(7), 100918. https://doi.org/10.1016/j.jpha.2023.12.008

Vancouver

Zhou W, Jiang RW, Bojko B, Pawliszyn J. Perspective on in vivo SPME for human applications: Starting from monitoring doxorubicin during lung chemo-perfusion. Journal of Pharmaceutical Analysis. 2024;14(7):100918. doi:10.1016/j.jpha.2023.12.008

BibTeX
@article{Zhou2024,
  author = {Zhou, Wei and Jiang, Runshan Will and Bojko, Barbara and Pawliszyn, Janusz},
  title = {Perspective on in vivo SPME for human applications: Starting from monitoring doxorubicin during lung chemo-perfusion},
  journal = {Journal of Pharmaceutical Analysis},
  year = {2024},
  volume = {14},
  number = {7},
  pages = {100918},
  doi = {10.1016/j.jpha.2023.12.008}
}
Kostenlos starten →